These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 12411399)

  • 1. Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis.
    Rössig L; Li H; Fisslthaler B; Urbich C; Fleming I; Förstermann U; Zeiher AM; Dimmeler S
    Circ Res; 2002 Nov; 91(9):837-44. PubMed ID: 12411399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling.
    Deroanne CF; Bonjean K; Servotte S; Devy L; Colige A; Clausse N; Blacher S; Verdin E; Foidart JM; Nusgens BV; Castronovo V
    Oncogene; 2002 Jan; 21(3):427-36. PubMed ID: 11821955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase.
    Gan Y; Shen YH; Wang J; Wang X; Utama B; Wang J; Wang XL
    J Biol Chem; 2005 Apr; 280(16):16467-75. PubMed ID: 15722551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial cell migration by an inhibitory effect on the Akt/endothelial nitric oxide synthase pathway.
    Chavakis E; Dernbach E; Hermann C; Mondorf UF; Zeiher AM; Dimmeler S
    Circulation; 2001 Apr; 103(16):2102-7. PubMed ID: 11319202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes.
    Kim MS; Kwon HJ; Lee YM; Baek JH; Jang JE; Lee SW; Moon EJ; Kim HS; Lee SK; Chung HY; Kim CW; Kim KW
    Nat Med; 2001 Apr; 7(4):437-43. PubMed ID: 11283670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase.
    Eto M; Barandiér C; Rathgeb L; Kozai T; Joch H; Yang Z; Lüscher TF
    Circ Res; 2001 Sep; 89(7):583-90. PubMed ID: 11577023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.
    Miura S; Matsuo Y; Saku K
    Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.
    Gélinas DS; Bernatchez PN; Rollin S; Bazan NG; Sirois MG
    Br J Pharmacol; 2002 Dec; 137(7):1021-30. PubMed ID: 12429574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation.
    Gonzalez C; Corbacho AM; Eiserich JP; Garcia C; Lopez-Barrera F; Morales-Tlalpan V; Barajas-Espinosa A; Diaz-Muñoz M; Rubio R; Lin SH; Martinez de la Escalera G; Clapp C
    Endocrinology; 2004 Dec; 145(12):5714-22. PubMed ID: 15358675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells.
    Bouloumié A; Schini-Kerth VB; Busse R
    Cardiovasc Res; 1999 Mar; 41(3):773-80. PubMed ID: 10435050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway.
    Shen BQ; Lee DY; Zioncheck TF
    J Biol Chem; 1999 Nov; 274(46):33057-63. PubMed ID: 10551875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis.
    Ushio-Fukai M; Tang Y; Fukai T; Dikalov SI; Ma Y; Fujimoto M; Quinn MT; Pagano PJ; Johnson C; Alexander RW
    Circ Res; 2002 Dec; 91(12):1160-7. PubMed ID: 12480817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside Rb1 blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries.
    Zhou W; Chai H; Lin PH; Lumsden AB; Yao Q; Chen C
    J Vasc Surg; 2005 May; 41(5):861-8. PubMed ID: 15886672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
    Mehta VB; Zhou Y; Radulescu A; Besner GE
    Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and regulation of endothelial nitric oxide synthase by vascular endothelial growth factor in ECV 304 cells.
    Park JS; Hong GR; Baek SW; Shin DG; Kim YJ; Shim BS
    J Korean Med Sci; 2002 Apr; 17(2):161-7. PubMed ID: 11961297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Akt kinase signals directly to endothelial nitric oxide synthase.
    Michell BJ; Griffiths JE; Mitchelhill KI; Rodriguez-Crespo I; Tiganis T; Bozinovski S; de Montellano PR; Kemp BE; Pearson RB
    Curr Biol; 1999 Jul 29-Aug 12; 9(15):845-8. PubMed ID: 10469573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase.
    Takemoto M; Sun J; Hiroki J; Shimokawa H; Liao JK
    Circulation; 2002 Jul; 106(1):57-62. PubMed ID: 12093770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells.
    Kroll J; Waltenberger J
    Biochem Biophys Res Commun; 1999 Nov; 265(3):636-9. PubMed ID: 10600473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism.
    Hrgovic I; Doll M; Pinter A; Kaufmann R; Kippenberger S; Meissner M
    Exp Dermatol; 2017 Feb; 26(2):194-201. PubMed ID: 27487811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.